Howe & Rusling’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
CCA
Howe & Rusling's RGEN Position: Q2 2021 in Review
Howe & Rusling sold out of Repligen (RGEN) in Q2 2021, closing a stake of 100 shares — an estimated $19K sold.
Howe & Rusling first reported a position in RGEN in Q1 2020 and held it in 5 quarters. The position peaked at $29K in Q4 2020. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.
- Howe & Rusling reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
- Howe & Rusling sold 100 Repligen shares in Q2 2021, an estimated $19K.
- Howe & Rusling first reported a position in Repligen in Q1 2020 and held it in 5 quarters.
- Howe & Rusling's Repligen position peaked at $29K in Q4 2020.
- 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.
Based on Howe & Rusling's 13F filing for Q2 2021, filed 13 Aug 2021.